Bolthouse Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Buy
493
+12
+2% +$12.3K 0.48% 38
2026
Q1
$442K Hold
481
0.4% 48
2025
Q4
$517K Hold
481
0.46% 43
2025
Q3
$367K Hold
481
0.33% 53
2025
Q2
$375K Sell
481
-219
-31% -$170K 0.37% 54
2025
Q1
$578K Hold
700
0.6% 36
2024
Q4
$540K Buy
+700
New +$580K 0.5% 42

Other funds holding LLY

Bolthouse Investments's LLY Position: Q2 2026 in Review

Bolthouse Investments increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $12.3K and bringing the position to 493 shares worth $591K. The position accounts for 0.48% of the portfolio, ranked #38.

Bolthouse Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bolthouse Investments held 493 shares of Eli Lilly worth $591K as of Q2 2026.
  • Bolthouse Investments bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.48% of Bolthouse Investments's portfolio in Q2 2026, its #38 holding.
  • Bolthouse Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bolthouse Investments's 13F filing for Q2 2026, filed 11 Aug 2026.